0000950170-24-021243.txt : 20240227 0000950170-24-021243.hdr.sgml : 20240227 20240227163042 ACCESSION NUMBER: 0000950170-24-021243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240224 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sprague John M CENTRAL INDEX KEY: 0001730056 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 24687382 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 ownership.xml 4 X0508 4 2024-02-24 0001492674 T2 Biosystems, Inc. TTOO 0001730056 Sprague John M 101 HARTWELL AVENUE LEXINGTON MA 02421 false true false false Chief Financial Officer false Common Stock 2024-02-24 4 M false 29 A 141 D Restricted Stock Units 2024-02-24 4 M false 29 0 D Common Stock 29 0 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On February 24, 2021 the reporting person was granted 87 RSU's that vest in three equal installments commencing on February 24, 2022. /s/ Michael Gibbs, Attorney-in-fact 2024-02-27